Hongwei He

Jiangxi University of Traditional Chinese Medicine — China

Medicine · Health Sciences

28h-index2.3kcitations113works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver physiology and pathology(27), Liver Disease Diagnosis and Treatment(24), Drug Transport and Resistance Mechanisms(12), Liver Diseases and Immunity(9), Cancer therapeutics and mechanisms(8)

Publications113 total

<i>In vivo</i> safety prediction of recombinant collagen using <i>in vitro</i> simulated degradation analysis, chronic toxicity and immunological evaluation
Regenerative Biomaterials·2025Open Access
Drug-drug interaction study between SHC014748M and itraconazole and rifampicin
2025Open Access
Corrigendum to “Study on the mechanism of reducing biofilm toxicity and increasing antioxidant activity in vinegar processing phytomedicines containing pentacyclic triterpenoid saponins” [J. Ethnopharmacol. 290 (2022) 115112]
Journal of Ethnopharmacology·2025
Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives
Molecules·2024· 7 citedOpen Access
Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway
Journal of Pharmaceutical Analysis·2024· 2 citedOpen Access
CircGNAO1 strengthens its host gene GNAO1 expression for suppression of hepatocarcinogenesis
Heliyon·2024· 1 citedOpen Access
Farnesoid X receptor modulator 12β-( <i>m</i> -methyl-benzoyl)-11,12-dihydro oleanolic acid represses liver fibrosis by inhibiting ERK/p38 signaling pathways
Toxicology Mechanisms and Methods·2024· 1 cited
Targeting Protein Phosphatases for the Treatment of Chronic LiverDisease
Current Drug Targets·2024· 2 cited
Enhanced Performance and High Resistance to Efficiency Degradation of Blue Quantum-Dot Light-Emitting Diodes Using the Lewis Base Blended Hole-Transporting Layers
ACS Applied Materials & Interfaces·2023· 3 cited
LncRNA-HANR exacerbates malignant behaviors of cholangiocarcinoma cells through activating Notch pathway
Heliyon·2023· 6 citedOpen Access
Design, synthesis and triglyceride-lowering activity of tricyclic matrine derivatives for the intervention of non-alcoholic fatty liver disease
Bioorganic Chemistry·2023· 5 cited
Evolution and Discovery of Matrine Derivatives as a New Class of Anti-Hepatic Fibrosis Agents Targeting Ewing Sarcoma Breakpoint Region 1 (EWSR1)
Journal of Medicinal Chemistry·2023· 7 citedOpen Access
Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy
Pharmaceuticals·2023· 6 citedOpen Access
Sclareol attenuates liver fibrosis through <scp>SENP1</scp>‐mediated <scp>VEGFR2 SUMOylation</scp> and inhibition of downstream <scp>STAT3</scp> signaling
Phytotherapy Research·2023· 12 cited
Discovery and development of benzene sulfonamide derivatives as anti-hepatic fibrosis agents
Bioorganic & Medicinal Chemistry Letters·2023· 4 cited
Can Axis C be a navigation route – CT comparison study between actual and virtual C1 transpedicular screw insertion
Journal of Clinical Neuroscience·2023
Short- and Long-Term Outcomes in Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Elderly Patients: A Systematic Review and Meta-Analysis
Journal of Laparoendoscopic & Advanced Surgical Techniques·2023· 5 cited
Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)
European Journal of Medicinal Chemistry·2022· 16 citedOpen Access
Advances in understanding the regulatory mechanism of organic solute transporter α-β
Life Sciences·2022· 6 cited
Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation
Journal of Ethnopharmacology·2022· 18 cited
page 1 of 6Next →

Frequent Co-authors

Rong‐Guang Shao(26), Mao‐xu Ge(10), Wuli Zhao(9), Shenghua Zhang(7), Dongke Yu(6), Danqing Song(6), Yunyang Bao(6), Naren Li(6), Weixiao Niu(5), Shi‐Ying Cai(4), Cai‐Xia Zhang(4), Zhen-Ning Lu(4), Na Zhang(3), Yixuan Zhang(3), Yong‐Zhan Zhen(3), Yiguang Wang(3), Kaihuan Ren(3), Juxian Wang(3), Shuangshuang Zhao(3), Yinghong Li(3)